CGA and neoplasm: In terms of biomarkers, CgA continues to be widely used for NEN diagnosis, as well as a monitoring tool for effectiveness of different anti-tumor treatments in patients with panNENs; however, its serum levels are frequently affected by several factors, particularly using proton pump inhibitors, which are now used for various indications in many patients worldwide [139,142].